Drug intelligence / Profile preview

Butedronic acid

Development stage: Preclinical
Lead developer: Bayer
Modality: Small Molecules
Administration: Intravenous

Overview

Butedronic acid is a synthetic bisphosphonate compound, chemically identified as 2-(diphosphonomethyl)butanedioic acid. It is classified as a bone resorption inhibitor. Its chemical structure includes two phosphonic acid groups, characteristic of bisphosphonates, which enable its binding to bone mineral. It has been investigated for its potential use as a diagnostic aid, particularly its 99mTc complex, which has been clinically evaluated as a skeletal imaging agent.

Other names: 2-(diphosphonomethyl)butanedioic acid(Diphosphonomethyl)succinic acid51395-42-7Acido butedronicoAcide butedronique26PB1U68YFBUTEDRONIC ACID [MI]3,3-DIPHOSPHONO-1,2-PROPANEDICARBONIC ACID [WHO-DD]acidum butedronicum(+-)-BUTEDRONIC ACIDDTXSID30866196DTXSID-30866196DTXSID 30866196CHEMBL2106599CHEMBL-2106599CHEMBL 2106599UNII-26PB1U68YFUNII26PB1U68YFUNII 26PB1U68YFSCHEMBL645294SCHEMBL-645294SCHEMBL 645294(+/-)-BUTEDRONIC ACIDCHEBI:135216LDTZSTJLVYBEKB-UHFFFAOYSA-N

Beyond the preview

Go deeper on Butedronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Butedronic acid.

Explore the full profile